[go: up one dir, main page]

WO1998024811A3 - Vascular endothelial growth factor - Google Patents

Vascular endothelial growth factor Download PDF

Info

Publication number
WO1998024811A3
WO1998024811A3 PCT/US1997/020888 US9720888W WO9824811A3 WO 1998024811 A3 WO1998024811 A3 WO 1998024811A3 US 9720888 W US9720888 W US 9720888W WO 9824811 A3 WO9824811 A3 WO 9824811A3
Authority
WO
WIPO (PCT)
Prior art keywords
growth factor
growth factors
vascular endothelial
endothelial growth
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1997/020888
Other languages
French (fr)
Other versions
WO1998024811A2 (en
Inventor
Teresa Gilbert
Darrel C Conklin
Charles E Hart
Sean Nygaard
Paul O Sheppard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Priority to AU54399/98A priority Critical patent/AU5439998A/en
Publication of WO1998024811A2 publication Critical patent/WO1998024811A2/en
Publication of WO1998024811A3 publication Critical patent/WO1998024811A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Growth factors, their component polypeptides, methods of making them, polynucleotides encoding them, and methods of using them are disclosed. The growth factors are homodimeric or heterodimeric proteins having component polypeptide chains that each comprises a sequence of amino acid residues that is at least 80 % identical in amino acid sequence to residues 109 to 197 of SEQ ID NO:2. The growth factors are mitogenic for fibroblasts and smooth muscle cells, and may be used therapeutically or in vitro to stimulate cell growth, or to develop inhibitors of cell growth.
PCT/US1997/020888 1996-12-06 1997-11-20 Vascular endothelial growth factor Ceased WO1998024811A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU54399/98A AU5439998A (en) 1996-12-06 1997-11-20 Vascular endothelial growth factor

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US75965796A 1996-12-06 1996-12-06
US08/759,657 1996-12-06
US93345597A 1997-09-18 1997-09-18
US08/933,455 1997-09-18

Publications (2)

Publication Number Publication Date
WO1998024811A2 WO1998024811A2 (en) 1998-06-11
WO1998024811A3 true WO1998024811A3 (en) 1998-10-01

Family

ID=27116713

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/020888 Ceased WO1998024811A2 (en) 1996-12-06 1997-11-20 Vascular endothelial growth factor

Country Status (2)

Country Link
AU (1) AU5439998A (en)
WO (1) WO1998024811A2 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7153827B1 (en) 1994-03-08 2006-12-26 Human Genome Sciences, Inc. Vascular endothelial growth factor 2 and methods of use
US5932540A (en) 1994-03-08 1999-08-03 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
US7109308B1 (en) 1994-03-08 2006-09-19 Human Genome Sciences, Inc. Antibodies to human vascular endothelial growth factor 2
US6608182B1 (en) 1994-03-08 2003-08-19 Human Genome Sciences, Inc. Human vascular endothelial growth factor 2
US6040157A (en) * 1994-03-08 2000-03-21 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
US7186688B1 (en) 1994-03-08 2007-03-06 Human Genome Sciences, Inc. Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2
US6734285B2 (en) 1994-03-08 2004-05-11 Human Genome Sciences, Inc. Vascular endothelial growth factor 2 proteins and compositions
CA2184584C (en) 1994-03-08 2003-04-08 Jing-Shan Hu Vascular endothelial growth factor 2
CA2231400A1 (en) 1995-09-08 1997-03-13 Genentech, Inc. Vegf-related protein
JP4086315B2 (en) 1995-09-29 2008-05-14 ユニベルシタ デグリ スチュディ ディ シエナ Regulatory genes and uses thereof
AU733322B2 (en) 1996-07-15 2001-05-10 Chugai Seiyaku Kabushiki Kaisha Novel VEGF-like factor
DK2107109T3 (en) 1996-08-23 2012-09-24 Vegenics Pty Ltd Recombinant vascular endothelial cell growth factor D (VEGF-D)
GB9624899D0 (en) 1996-11-29 1997-01-15 Schlumberger Ltd Method and apparatus for measuring flow in a horizontal borehole
KR100628697B1 (en) 1997-12-24 2006-09-28 루드빅 인스티튜트 포 캔서 리서치 Expression Vectors and Cell Lines Expressing Vascular Endothelial Growth Factor D and Methods of Treating Melanoma
US6958147B1 (en) 1998-10-26 2005-10-25 Licentia Ltd Use of VEGF-C to prevent restenosis
DE69939330D1 (en) * 1998-12-07 2008-09-25 Zymogenetics Inc GROWTH FACTOR HOMOLOGIST ZVEGF-3
ES2259247T3 (en) * 1998-12-21 2006-09-16 Ludwig Institute For Cancer Research ANTIBODIES AGAINST TRUNCATED VEGF-D AND ITS USES.
US6783953B1 (en) 1998-12-22 2004-08-31 Janssen Pharmaceutica N.V. Vascular endothelial growth factor-X
AU778412B2 (en) * 1998-12-22 2004-12-02 Janssen Pharmaceutica N.V. Vascular endothelial growth factor-X
US7223724B1 (en) 1999-02-08 2007-05-29 Human Genome Sciences, Inc. Use of vascular endothelial growth factor to treat photoreceptor cells
CA2370948C (en) * 1999-05-03 2012-07-31 Zymogenetics, Inc. Growth factor homolog zvegf4
JP2003507006A (en) 1999-05-20 2003-02-25 サイオス，インコーポレーテッド Vascular endothelial growth factor variant
WO2002011769A1 (en) 2000-08-04 2002-02-14 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
US7067317B2 (en) 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US7026462B2 (en) 2000-12-07 2006-04-11 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US7402312B2 (en) 2001-04-13 2008-07-22 Human Genome Sciences, Inc. Antibodies to vascular endothelial growth factor 2 (VEGF-2)
EP2228389B1 (en) 2001-04-13 2015-07-08 Human Genome Sciences, Inc. Antibodies against vascular endothelial growth factor 2
US7358085B2 (en) 2005-02-28 2008-04-15 Sangamo Biosciences, Inc. Anti-angiogenic methods and compositions

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996026736A1 (en) * 1995-03-01 1996-09-06 Ludwig Institute For Cancer Research Vascular endothelial growth factor-b
WO1997012972A2 (en) * 1995-09-29 1997-04-10 Universita'degli Studi Di Siena Regulated genes and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996026736A1 (en) * 1995-03-01 1996-09-06 Ludwig Institute For Cancer Research Vascular endothelial growth factor-b
WO1997012972A2 (en) * 1995-09-29 1997-04-10 Universita'degli Studi Di Siena Regulated genes and uses thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
NILSSON, B. ET AL.: "Expression and purification of recombinant insulin-like growth factors from Escherichia coli", METHODS IN ENZYMOLOGY, vol. 198, 1991, pages 3 - 16, XP002073019 *
ORLANDINI, M. ET AL.: "Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 93, October 1996 (1996-10-01), WASHINGTON US, pages 11675 - 11680, XP002029340 *
YAMADA, Y. ET AL.: "Molecular cloning of a novel Vascular Endothelial Growth Factor, VEGF-D", GENOMICS, vol. 42, no. 3, 15 June 1997 (1997-06-15), pages 483 - 488, XP002073018 *

Also Published As

Publication number Publication date
AU5439998A (en) 1998-06-29
WO1998024811A2 (en) 1998-06-11

Similar Documents

Publication Publication Date Title
WO1998024811A3 (en) Vascular endothelial growth factor
EP1626096A3 (en) In vitro method of detecting a cell proliferative disorder involving fibroblast growth factor homologous factor-1 (FHF-1)
CA2263889A1 (en) P-selectin ligand proteins
CA2054699A1 (en) Growth of vascular endothelial cell growth factor and dna encoding same
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
CA2095153A1 (en) Genetic modification of endothelial cells
CA2108473A1 (en) Heregulins (hrgs) binding proteins of p185erb2
WO1988009818A3 (en) Growth hormone receptor
AU7180787A (en) Fibroblast growth factor
ZA835880B (en) Dna sequences,recombinant dna molecules and processes for producing bovine growth hormone-like polypeptides in high yield
WO1989009787A3 (en) Osteogenic devices
ES2147558T3 (en) NEW POLYPEPTIDES TO PROMOTE CELL FIXATION.
WO2000034474A3 (en) Growth factor homolog zvegf3
EP1396542A3 (en) P-Selectin Ligand Protein
IL127583A0 (en) Method for the production of polypeptides
NZ512942A (en) Polynucleotides encoding the IL-13 binding chains of the interleukin receptor, pharmaceutical compositions comprising the protein and methods of identifying inhibitors
ZA897020B (en) Derivatives of human/bovine basic fibroblast growth factor
GB8821785D0 (en) Peptide compounds
EP0319315A3 (en) The von willebrand factor binding domain of factor viii
WO1999032515A3 (en) Angiopoietin homolog, dna encoding it, and method of making it
JPS6455181A (en) Artificial protein having particular amino acid composition and method for preparation thereof
Sugiyama et al. Rapid purification and characterization of histatins (histidine-rich polypeptides) from human whole saliva
MXPA01011158A (en) Growth factor homolog zvegf4.
AU6406590A (en) Porcine lactoferrin amino acid and cdna sequence
IL131103A0 (en) The neurotrophic factor nnt-1

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase